“…In particular, endovascular revascularization guarantees lower short-term adverse events, especially in PAD patients characterized by significant frailty related to comorbidities [ [198] , [199] , [200] , [201] ]. First, surgical suitability should be always evaluated [ 202 , 203 ] and endovascular revascularization should be offered as a second valid option in patients with high surgical risks or unfavorable vascular characteristics [ 204 ], although a higher incidence of MALE was observed. The most suitable surgical strategy should be determined considering personal characteristics and the individual surgical risks [ 205 ].…”